Applications of Marine Organism-Derived Polydeoxyribonucleotide: Its Potential in Biomedical Engineering.
Level 5 - mechanism / opinion, no new human data
Narrative review summarizing mechanisms, preclinical data, and applications
PubMed 34067499 · doi:10.3390/md19060296
What was done
The authors conducted a narrative literature review searching Google Scholar to assess recent trends, pharmacological mechanisms, and biomedical engineering applications of marine organism-derived polydeoxyribonucleotide (PDRN) extracted primarily from salmon trout or chum salmon sperm.
What was found
The abstract provides no quantitative data or statistical comparisons. It describes PDRNs (molecular weight 50–1500 kDa) as agents that promote wound healing and reduce inflammation through adenosine A2A receptor stimulation and salvage pathways, with reported downstream effects on osteoblast activity, collagen synthesis, and angiogenesis.
Why it matters
This review synthesizes the biological mechanisms and clinical applications of marine-derived PDRN to inform the design of future regenerative and tissue-engineering technologies.
Limits
The abstract reports no numerical results, effect sizes, sample sizes, or total count of evaluated studies. The methodology relied on Google Scholar rather than a structured multi-database systematic review, precluding formal quality appraisal or risk of bias assessment.
Cited by
- supports PDRN (polydeoxyribonucleotides) used in injectable skin treatments is derived from salmon sperm DNA.